About
BioLamina is a company that grew out of extracellular matrix research at the Karolinska Institute in Sweden, and makes Biolaminin®, a full-length human recombinant laminin cell culture matrix. It is used for the culture and differentiation of human pluripotent stem cells (hESC and hiPSC), and Cell Therapy Grade (CTG) products are available for clinical cell applications.
Products
Product Lines
Biolaminin 521
- Biolaminin 521 CTG — Cell Therapy Grade for clinical cell applications
- Biolaminin 521 MX — for research aimed at clinical application
- Biolaminin 521 LN — for pluripotent stem cell culture
Biolaminin isoforms
- Biolaminin 511 · 421 · 411 LN
- Biolaminin 332 · 221 · 211 · 121 · 111 LN
Biosilk (3D culture)
- Biosilk
- Biosilk 521
How to choose
Product Selection Information
Main Uses
- Culture of human pluripotent stem cells (hESC · hiPSC)
- Maintenance of differentiated cells
- Clinical cell applications (CTG grade)
Selection Criteria
- Stage of use: research or clinical application
- Grade: choose from CTG · MX · LN
- Cell type and culture method
- Level of requirements regarding animal-derived components
- Technical documents to request: certificates of analysis · grade-specific quality documents
Confirmed Specifications & Options
- Biolaminin 521 CTG: for clinical cell applications, Cell Therapy Grade
- Biolaminin 521 MX: for research aimed at clinical application
- Biolaminin 521 LN: for pluripotent stem cell culture
- Type: full-length human recombinant laminin
- CTG: free of animal-derived components (animal origin-free)
What to Tell Us
- Cell type and purpose of culture
- Development stage: research · preclinical · clinical
- Desired grade (CTG · MX · LN)
- Coating substrate currently in use
- Culture scale and quantity needed